Isoindole-1,3-dione derivatives as RSK2 inhibitors: synthesis, molecular docking simulation and SAR analysis
作者:Wei Zhou、Shiliang Li、Weiqiang Lu、Jun Yuan、Yufang Xu、Honglin Li、Jin Huang、Zhenjiang Zhao
DOI:10.1039/c5md00469a
日期:——
RSK2 (p90 ribosomal S6 kinase 2) is a serine/threonine kinase expressed in a variety of cancers. Molecular-targeted inhibition of RSK2 as a potential therapeutic strategy for human cancers has been documented. In this work, a series of isoindole-1,3-dione derivatives as novel RSK2 inhibitors were designed and synthesized from a hit discovered in our previous study. Some compounds were confirmed to
RSK2(p90核糖体S6激酶2)是在多种癌症中表达的丝氨酸/苏氨酸激酶。已经证明了分子靶向抑制RSK2作为人类癌症的潜在治疗策略。在这项工作中,从我们先前的研究中发现的命中物中,设计并合成了一系列新型RSK2抑制剂异吲哚-1,3-二酮衍生物。已确认某些化合物是中等有效的RSK2抑制剂,IC 50值约为0.5μM。通过分子对接进行结构-活性关系分析和结合模式研究。